Australia TGA ARTG recordExabone Paste - Graft, bone, synthetic
Australia TGA ARTG Registered Device · LMT Surgical Pty Ltd · Exabone GmbH · Class III · Started January 21, 2015
Good Name: LMT Surgical Pty Ltd - Exabone Paste - Graft, bone, synthetic
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- January 21, 2015
- Effective Date
- January 21, 2015
- Name
- Exabone GmbH
- Country
- Switzerland
- Address
- Route de Saint-Cergue14, Nyon, CH1260
EXABONE PASTE is a synthetic osteoconductive bone paste intended to be used for filling and supporting the ingrowth of adjacent viable bone in bone defects that are not intrinsic to the stability of the bone structure. These defects may be located in the extremities, pelvis or dental, periodontal or mandibular areas, fractures, resection of benign tumours or cysts, for filling autograft harvest sites, for alveolar ridge or wall inclusive extraction sockets, and for filling of periodontal bone defects. EXABONE PASTE will act as a temporary scaffold and will remain as a soft paste and is not intended to provide structural support during the healing process. The implant is biocompatible, radio-opaque and will resorb in a controlled way.
Access comprehensive regulatory information for Exabone Paste - Graft, bone, synthetic in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by LMT Surgical Pty Ltd, manufactured by Exabone GmbH in Switzerland. The device registration started on January 21, 2015.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.